Skip to main content

Table 1 Patients' demographic and clinical characteristics stratified according to serum 25-OH vitamin D levels

From: The association between preoperative 25-OH vitamin D levels and postoperative complications in patients undergoing colorectal cancer surgery

Variables

Study population N (%) or mean (± SD) (n = 104)

25-OH Vit D < 20 ng/ml N (%) or mean (± SD) (n = 74)

25-OH Vit D ≥ 20 ng/ml N (%) or mean (± SD) (n = 30)

p value

Age (years)

62.71 (± 12.41)

63.28 (± 11.76)

61.30 (± 14.01)

0.463

Gender:

   

0.516

 Female

40 (38.5%)

27 (36.5%)

13 (43.4%)

 

 Male

64 (61.5%)

47 (63.5%)

17 (56.7%)

 

ASA scores:

   

0.043*

 1

17 (16.3%)

8 (10.8%)

9 (30%)

 

 2

56 (53.8%)

41 (55.4%)

15 (50%)

 

 3

31 (29.8%)

25 (33.8%)

6 (20%)

 

NRS scores:

   

0.106

 0

58 (55.8%)

38 (51.4%)

20 (66.7%)

 

 1

31 (29.8%)

22 (29.7%)

9 (30%)

 

 2

15 (14.4%)

14 (18.9%)

1 (3.3%)

 

CEA (µg/l)

7.4 (± 11.6)

7.44 (± 12.94)

6.56 (± 6.76)

0.758

Albumin (gr/dl)

3.8 (± 0.5)

3.88 (± 0.51)

3.87 (± 0.49)

0.832

Hemoglobin (gr/l)

12.6 (± 1.99)

12.11 (± 2.0)

12.26 (± 1.98)

0.714

WBC (103/µl)

8080 (± 2274)

8340 (± 2479)

7440 (± 1517)

0.169

Tumor location:

 

51 (68.9%)

23 (76.7%)

0.011*

 Colon

74 (71.1%)

23 (31.1%)

7 (23.3%)

 

 Rectum

30 (28.8%)

   

Operative procedures:

   

0.325

 Right hemicolectomy

20 (19.2%)

16 (21.6%)

4 (13.3%)

 

 Extended right hemicolectomy

5 (4.8%)

5 (6.8%)

 

 Left hemicolectomy

6 (5.8%)

5 (6.8%)

1 (3.3%)

 

 Extended left hemicolectomy

8 (7.7%)

5 (6.8%)

3 (10%)

 

 Anterior resection

14 (13.5%)

9 (12.2%)

5 (16.7%)

 

 Low anterior resection

39 (37.5%)

24 (32.4%)

15 (50%)

 

 Abdominoperineal resection

6 (5.8%)

6 (8.1%)

 

 Total colectomy

6 (5.8%)

4 (5.4%)

2 (6.7%)

 

pTNM staging:

   

0.036*

 I

19 (18.3%)

16 (21.6%)

3 (10%)

 

 IIa

35 (33.7%)

23 (31.1%)

12 (40%)

 

 IIb

9 (8.7%)

8 (10.8%)

1 (3.3%)

 

 IIc

1 (1%)

1 (3.3%)

 

 IIIa

5 (4.8%)

3 (4.1%)

2 (6.7%)

 

 IIIb

26 (25%)

21 (28.4%)

5 (16.7%)

 

 IIIc

7 (6.7%)

2 (2.7%)

5 (16.7%)

 

 IVc

1 (1%)

1 (3.3%)

 

Pathological grading:

   

0.693

 G1 (well differentiated)

22 (21.8%)

17 (23.6%)

5 (17.2%)

 

 G2 (moderately differentiated)

74 73.3%)

52 (72.2%)

22 (75.9%)

 

 G3 (poorly differentiated)

5 (5%)

3 (4.2%)

2 (6.9%)

 
  1. SD, standard deviation; ASA, American Society of Anesthesiologists; NRS, Nutritional Risk Score-2002; CEA, carcinoembryonic antigen; WBC, White blood cells; pTNM, pathological tumor-node-metastasis
  2. * Variables with p value < 0.05